P.6.f.005 Prevalence of substance use and the relation with psychosis and catechol-O-methyltransferase in patients with chromosome 22q11 deletion syndrome

2015 ◽  
Vol 25 ◽  
pp. S630 ◽  
Author(s):  
W.A.M. Vingerhoets ◽  
M.J.F. Van Oudenaren ◽  
E.D.A. Van Duin ◽  
O.J.N. Bloemen ◽  
J. Booij ◽  
...  
2006 ◽  
Vol 16 (4) ◽  
pp. 454-457 ◽  
Author(s):  
HIROE YOTSUI-TSUCHIMOCHI ◽  
KAZUO HIGA ◽  
MATSUKO MATSUNAGA ◽  
KEIICHI NITAHARA ◽  
SHINJIRO SHONO

2009 ◽  
Vol 10 (1) ◽  
Author(s):  
Chen Yang ◽  
Cheng-Hung Huang ◽  
Mei-Leng Cheong ◽  
Kun-Long Hung ◽  
Lung-Huang Lin ◽  
...  

2004 ◽  
Vol 132 (3) ◽  
pp. 273-278 ◽  
Author(s):  
Andreas Reif ◽  
Andreas J. Fallgatter ◽  
Ann-Christine Ehlis ◽  
Klaus-Peter Lesch

2011 ◽  
Vol 17 (5) ◽  
pp. e123-e125 ◽  
Author(s):  
Jaspreet Kambo ◽  
Christian Girgis ◽  
Bernard Champion ◽  
Jack Wall

2002 ◽  
Vol 44 (01) ◽  
pp. 44 ◽  
Author(s):  
Lena Niklasson ◽  
Peder Rasmussen ◽  
Sólveig Óskarsdóttir ◽  
Christopher Gillberg

2008 ◽  
Vol 45 (5) ◽  
pp. 561-566 ◽  
Author(s):  
Nancy Mizue Kokitsu-Nakata ◽  
Maria Leine Guion-Almeida ◽  
Antonio Richieri-Costa

Objective: To report on two Brazilian patients with chromosome 22q11 deletion who presented with velopharyngeal insufficiency, congenital heart anomalies, developmental delay, and limb anomalies. The pattern of limb anomalies in these patients, which range from ectrodactyly to limb synostosis, is very uncommon in 22q11 deletion syndrome. Conclusion: These patients widen the spectrum of clinical signs of the 22q11 deletion syndrome and alert researchers to conduct additional investigation in patients with limb involvement with velopharyngeal insufficiency and/or cardiac anomalies, along with developmental delay.


2004 ◽  
Vol 89 (10) ◽  
pp. 4817-4820 ◽  
Author(s):  
Naim M. Maalouf ◽  
Khashayar Sakhaee ◽  
Clarita V. Odvina

Abstract Congenital hypoparathyroidism typically manifests with hypocalcemia with or without associated characteristic physical findings and is usually diagnosed during the neonatal period. This report describes an African-American male who was diagnosed at age 32 yr to have dysgenesis of the parathyroid glands due to chromosome 22 microdeletion. Symptomatic hypocalcemia did not develop until age 14 yr, a few weeks after initiation of anticonvulsant therapy for generalized tonic-clonic seizures. Because of the timing for onset of symptomatic hypocalcemia, it was presumed that the patient had anticonvulsant-induced hypocalcemia, and he carried that diagnosis for 18 yr. Chromosome 22q11 deletion syndrome was first suspected at age 32 yr, based on the findings of subtle dysmorphic facial features and a history of learning disability in a patient with PTH-deficient hypocalcemia. The diagnosis was confirmed by fluorescence in situ hybridization analysis. This case underscores the variable clinical presentation of this congenital form of hypoparathyroidism. Chromosome 22q11 microdeletions are relatively common, and the diagnosis should be considered even in adults with hypoparathyroidism because of the potential benefit of genetic counseling.


Sign in / Sign up

Export Citation Format

Share Document